Table 2.
Validation results of the accuracy for sunitinib, cilostazol, and olmesartan medoxomil.
| Analyte | Accuracy Mean Recovery 60–115% RSD ≤ 21% (n = 9) |
||
|---|---|---|---|
| Sunitinib Malate |
Cilostazol | Olmesartan Medoxomil |
|
| NDMA | 94.45 | 98.26 | 104.66 |
| 1.98 | 2.11 | 5.68 | |
| NMEA | 94.09 | 99.14 | 95.85 |
| 2.10 | 1.78 | 4.24 | |
| NDEA | 97.97 | 97.15 | 97.34 |
| 3.57 | 2.02 | 4.44 | |
| NDPA | 97.07 | 95.91 | 92.20 |
| 5.05 | 2.15 | 6.50 | |
| NMOR | 111.22 | 97.10 | 103.60 |
| 2.89 | 3.66 | 5.16 | |
| NPYR | 95.87 | 100.62 | 108.72 |
| 3.82 | 3.00 | 5.29 | |
| NPIP | 99.37 | 96.66 | ND |
| 5.13 | 6.02 | ||
| NDBA | 99.30 | 104.87 | 102.17 |
| 6.10 | 2.38 | 8.98 | |
| N-methyl-npz | 102.94 | 99.90 | ND |
| 7.53 | 5.17 | ||
ND—not detected.